Medication info
Twindown Tablet 40/10 Milligrams

Twindown Tablet 40/10 Milligrams

Prescription medicationOral
Ingredient · strength
Telmisartan Powder 23.9%›167.36mg / 1 tabletAmlodipine Besylate›13.87mg / 1 tablet
Manufacturer / importer
Mothers Pharma Co., Ltd.
Appearance
This is a bilayer tablet that is oval-shaped and convex on both sides, colored white and light gray.
Packaging
30 tablets (10 tablets/PTP X 3)
Approval status
Active

MFDS item code 201804758 · Approved 2018.11.29 · Insurance code 622803330

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan) before starting this drug; however, if blood pressure is not controlled with the individual components as described below, switching directly to this drug may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this drug 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients who should be administered this drug with caution’). In patients 75 years of age or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.
Child dose
○ Pediatric patients: The safety and efficacy of this drug have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
Mothers Pharma Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used to effectively manage blood pressure in patients with essential hypertension whose blood pressure is not adequately controlled with amlodipine or telmisartan monotherapy.

How to take

Adult dose

The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan) before starting this drug; however, if blood pressure is not controlled with the individual components as described below, switching directly to this drug may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this drug 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients who should be administered this drug with caution’). In patients 75 years of age or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.

Child dose

○ Pediatric patients: The safety and efficacy of this drug have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Precautions

This medication can pose serious risks to the fetus during pregnancy, particularly in the second and third trimesters, and should not be used by women who are pregnant or could become pregnant. Patients with allergies to any components of this medication, those with severely impaired liver function, those with obstructive biliary disease, severe hypotension, or severely compromised heart function should not use this medication. Patients with certain heart valve diseases, liver dysfunction, gastrointestinal diseases, renal vascular diseases, and elderly patients should use this medication with special caution. Common side effects may include dizziness, edema, and hypotension; while serious side effects are rare, they may occur, and if symptoms manifest, prompt consultation with healthcare professionals is necessary. Women who are pregnant or planning to become pregnant should switch to other antihypertensive medications that have been proven safe, and if pregnancy is confirmed, should discontinue this drug immediately. While taking this medication, blood pressure may drop too low. Therefore, especially patients with deficiencies in fluid or sodium should consult with their doctor before use and monitor their condition carefully. There is a risk of increased potassium levels in the blood, so caution is required when taking potassium supplements or potassium-containing foods, and regular blood tests are advisable. Patients with compromised kidney function should have their renal function monitored regularly while on this medication, and safety has not been established in kidney transplant patients. Patients with heart disease should be particularly careful, as the risk of angina or myocardial infarction may increase when using this medication. This medication may cause drowsiness or dizziness, so it is advisable to avoid driving or operating dangerous machinery while taking it. This medication may interact with other drugs, so if you are currently taking other medications, make sure to inform your doctor or pharmacist. Breastfeeding women should avoid taking this medication, and it is not recommended for children and adolescents under the age of 18, as safety and efficacy have not been sufficiently established. In the event of overdose, symptoms such as hypotension, tachycardia, and dizziness may occur, and appropriate treatment should be sought immediately. This medication should be kept out of reach of children, and it is important to avoid moisture and store it in its original packaging.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory tract infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 96 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • anxiety
  • confusional state
  • drowsiness
  • headache
  • sensory disturbance
  • sensory loss
  • taste disturbance
  • tremor
  • extrapyramidal disorder
  • muscle rigidity
  • visual impairment
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • cough
  • dyspnea
  • rhinitis
  • change in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gum hypertrophy
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver dysfunction
  • liver impairment
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • alopecia
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug eruption
  • urticaria
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • back pain
  • limb pain
  • tendon pain
  • renal impairment
  • urinary disorders
  • frequent urination
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • elevated liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin
  • intestinal vascular edema

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a container that protects it from light. Additionally, it is important to maintain room temperature, between 1 degree and 30 degrees Celsius, when storing the medication. This helps maintain its effectiveness and prevents deterioration.

Appearance and packaging

Appearance

This is a bilayer tablet that is oval-shaped and convex on both sides, colored white and light gray.

Package unit

30 tablets (10 tablets/PTP X 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.